Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 06, 2024

BUY
$21.55 - $29.29 $1,077 - $1,464
50 Added 20.0%
300 $7,000
Q3 2023

Aug 06, 2024

BUY
$26.74 - $40.81 $2,674 - $4,081
100 Added 66.67%
250 $7,000
Q1 2022

Aug 06, 2024

BUY
$49.85 - $96.11 $7,477 - $14,416
150 New
150 $9,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.